Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 4 min ago

Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction

Tue, 02/18/2014 - 13:50
Creates an Innovative New Model in Specialty Pharmaceuticals Leadership, with $15 Billion in Revenue and a Growing ~$7 Billion North American Specialty Brand Business Blockbuster Franchises in CNS, Gastroenterology, Women's Health, Urology and Cardiovas...
Biopharmaceuticals, Mergers & Acquisitions
Actavis, Forest Laboratories

New Smart Tool Approved by Health Canada for Enhancing Hip Replacement Surgery

Tue, 02/18/2014 - 13:43
Early study results of Intellijoint Surgical's device show superior accuracy of key metrics for successful hip replacement WATERLOO, ONTARIO--(Healthcare Sales & Marketing Network) - Intellijoint Surgical, Inc. (formerly Avenir Medical) an innovator in ...
Devices, Regulatory, Orthopaedic
Intellijoint Surgical, Avenir Medical, Intellijoint HIP, hip replacement

Avillion Appoints Dr Allison Jeynes-Ellis as Chief Executive Officer

Tue, 02/18/2014 - 13:21
LONDON, February 18, 2014 -- (Healthcare Sales & Marketing Network) --Avillion LLP, a drug development company focused on co-development and financing of late-stage pharmaceutical candidates, from Phase 3 clinical development to marketing approval, announ...
Biopharmaceuticals, Personnel
Avillion, BOSULIF, bosutinib

Bayer's Long-Acting Recombinant Factor VIII Demonstrated Prophylaxis with Less Frequent Infusions in Hemophilia A in Phase III Trial

Tue, 02/18/2014 - 13:09
The PROTECT VIII study met its primary efficacy and safety objectives for the treatment of patients with hemophilia A BAY 94-9027 helped protect against bleeds when used prophylactically with infusion intervals up to seven days WHIPPANY, N.J., Feb. 1...
Biopharmaceuticals
Bayer HealthCare Pharmaceuticals, BAY 94-9027, factor VIII, hemophilia

Quest Diagnostics Announces Senior Leadership Appointments

Mon, 02/17/2014 - 21:39
John B. Haydon transitions to Vice President, Joint Ventures and Strategic Programs James E. Davis named Senior Vice President, Operations Lidia L. Fonseca named Senior Vice President and Chief Information Officer MADISON, N.J., Feb. 17, 2014 -- (...
Diagnostics, Personnel
Quest Diagnostics

Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome

Mon, 02/17/2014 - 13:05
Researchers Conclude Molecular Test Is Able to Differentiate High and Low Recurrence Risk up to 25 Years after Diagnosis, Further Validating NEJM Study IRVINE, Calif. & AMSTERDAM--(Healthcare Sales & Marketing Network)--A newly published study concludes...
Diagnostics, Oncology
Agendia, MammaPrint, breast cancer

New Study Affirms In-Office Multi-Sinus Balloon Dilation is an Effective, Well Tolerated Treatment Option for Chronic Sinusitis Sufferers

Mon, 02/17/2014 - 12:59
Physicians achieved high technical success rate using Entellus Medical's XprESS multi-sinus dilation device to dilate the maxillary, frontal and sphenoid sinuses MINNEAPOLIS--(Healthcare Sales & Marketing Network)--A new study published in the American ...
Devices
Entellus Medical, balloon dilation, sinusitis, multisinus balloon dilation

CoStim Pharmaceuticals, Inc. Acquired by Novartis

Mon, 02/17/2014 - 12:51
BOSTON, Feb. 17, 2014 -- (Healthcare Sales & Marketing Network) -- MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. ("CoStim") has been acquired by Novartis for an undisclosed amount. CoStim, foun...
Biopharmaceuticals, Mergers & Acquisitions
MPM Capital, CoStim Pharmaceuticals, Novartis

Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)

Mon, 02/17/2014 - 12:47
STOCKHOLM--(Healthcare Sales & Marketing Network)--NeuroVive Pharmaceutical AB (publ)(NVP.ST), a leading mitochondrial medicine company, has reported that the last of a total of 972 patients have now been enrolled and treated in its ongoing European phase ...
Biopharmaceuticals, Cardiology
NeuroVive Pharmaceutica, CicloMulsion, reperfusion injury

BMG PHARMA S.r.l - Milan, Italy - Has Granted Exclusive Distribution Rights to Samyang Biopharmaceutical Corporation for GelX(R) in the Territory of South Korea

Mon, 02/17/2014 - 12:40
MILAN, February 17, 2014 -- (Healthcare Sales & Marketing Network) --BMG Pharma S.r.l. today is pleased to announce that it has signed an exclusive distribution agreement with Samyang Biopharmaceutical Corporation granting them the rights to promote, sell...
Biopharmaceuticals, Licensing, Distribution
BMG Pharma, Samyang Biopharmaceutical, mucositis, GelX

Bioventus Names Allison London Brown New VP of Global Marketing

Fri, 02/14/2014 - 13:01
DURHAM, N.C.--(Healthcare Sales & Marketing Network)--Bioventus, a leader in active orthopedic healing, today announced that Allison London Brown has joined the company as its new Vice President of Global Marketing. London Brown is based in the company’s D...
Devices, Orthopaedic, Personnel
Bioventus

Teleflex launches the Rusch(R) DispoLED(TM) Laryngoscope Handle

Fri, 02/14/2014 - 12:56
Single-use fiber optic technology designed to help improve clinical practice LIMERICK, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced th...
Devices, Product Launch
Teleflex, Rusch, DispoLED, Laryngoscope Handle

Stereotaxis Appoints William C. Mills III to Chief Executive Officer

Fri, 02/14/2014 - 12:50
T. LOUIS, Feb. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that its board of directors has appointed Chairman William C. Mills III to Chief Executive Officer, effective February 12, 2014. Mr. Mills has bee...
Devices, Cardiology, Personnel
Stereotaxis, Epoch, Niobe, Odyssey

AVEO and Astellas to End Worldwide Collaboration and License Agreement for Development and Commercialization of Tivozanib

Fri, 02/14/2014 - 12:46
Phase 2 Colorectal Cancer Study Discontinued AVEO to Outline Corporate Strategy During 2013 Financial Results Conference Call on March 13, 2014 CAMBRIDGE, Mass. & TOKYO--(Healthcare Sales & Marketing Network)--AVEO Oncology (AVEO) and Astellas Pharm...
Biopharmaceuticals, Oncology, Licensing
AVEO Oncology, Astellas Pharma, Tivozanib

Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe

Thu, 02/13/2014 - 18:43
New Peripheral Angioplasty Balloon Targets Challenging Lesions in Lower-Extremity, Including Below-the-Knee, Arteries Associated with Critical Limb Ischemia MINNEAPOLIS -- Feb. 13, 2014 --(Healthcare Sales & Marketing Network)-- Aligned with its commitm...
Devices, Interventional, Product Launch
Medtronic, TOTAL across, crossing catheter, Angioplasty, Balloon catheter

Medtronic Begins Distribution of i-port Advance(R) Injection Port Device for People with Diabetes

Thu, 02/13/2014 - 18:39
Distribution Rights Broaden Medtronic`s Diabetes Management Solutions to Include Injection Therapy Assistance MINNEAPOLIS - February 13, 2014 --(Healthcare Sales & Marketing Network)--Medtronic, Inc. (MDT) has begun distribution of i-port Advance® a...
Devices, Drug Delivery, Endocrinology, Product Launch
Medtronic, i-port Advance, Injection Port, diabetes

Principia Biopharma Expands Executive Management Team

Thu, 02/13/2014 - 14:31
Industry veterans join company as it advances its pipeline to clinical stage in 2014 SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Principia Biopharma Inc., a privately-held biopharmaceutical company focused on developing best-in-...
Biopharmaceuticals, Personnel
Principia Biopharma

Ornim Medical Announces New Study Results Demonstrating the Value of the CerOx(TM) Cerebral Oxygen Monitor in the Treatment of Patients With Severe Traumatic Brain Injury

Thu, 02/13/2014 - 14:27
Healthcare Professionals Can Learn More About Ornim's Groundbreaking Technology at the International Stroke Conference From February 12-14, 2014, in San Diego KFAR SABA, ISRAEL--(Healthcare Sales & Marketing Network) - Ornim Medical, Inc., a biomedical ...
Devices, Monitoring, Neurosurgery
Ornim Medical, CerOx, cerebral oxygen, traumatic brain injury

Regulus Appoints Head of Regulus microMarkers(TM) RandD Division

Thu, 02/13/2014 - 14:23
Martin Beaulieu, Ph.D. Brings Extensive Diagnostic Assay Development Experience Regulus microMarkers™ Designed to Support Regulus' Therapeutic Pipeline, its Collaborators and Strategic Partners LA JOLLA, Calif., Feb. 13, 2014 -- (Healthcare Sales & M...
Biopharmaceuticlas, Personnel
Regulus Therapeutics, microMarkers, microRNA

Excelsior Medical Files Patent Infringement Suit Against Ivera Medical

Thu, 02/13/2014 - 14:18
NEPTUNE, N.J.--(Healthcare Sales & Marketing Network)--Excelsior Medical Corp. today announced that it has filed a lawsuit against Ivera Medical, Inc. for patent infringement arising under the patent laws of the United States of America, 35 U.S.C. § 1...
Devices, Litigation
Excelsior Medical, Ivera Medical, Curos Strip, Curos Tips

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong